Keynote Speakers
Balaji Panchapakesan
Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI) | 
John Palma
Chief Medical Officer, Roche Sequencing Solutions | 
Sehyun Shin
Professor & Director, Nano-Biofluignostic Engineering Research Center, Korea University and Anam/Guro Hospital of Korea University | 
Erkki Ruoslahti
Distinguished Professor and Former President, Sanford Burnham Prebys Medical Discovery Institute | 
Jennifer Jones
Staff Clinician, Molecular Immunogenetics & Vaccine Research Section, National Cancer Institute (NCI) | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, Adjunct Professor, Ulsan National Institute of Science & Technology, William H. Pryor Emeritus Chair of Chemistry, The University of Kansas |
|
Sam Hanash
Director, McCombs Institute for Cancer Detection and Treatment, University of Texas MD Anderson Cancer Center | 
David Hoon
Professor, Director Department of Translational Molecular Medicine, John Wayne Cancer Institute | 
Hatim Husain
Assistant Professor of Medicine, University of California San Diego | 
Filip Janku
Associate Professor, Center Medical Director, Clinical and Translational Research Center, The University of Texas MD Anderson Cancer Center | 
Cheng-Ho Jimmy Lin
Chief Scientific Officer, Oncology, Natera | 
Lydia Sohn
Professor, Department of Mechanical Engineering, University of California, Berkeley |
OverviewSELECT BIO Liquid Biopsies 2019 focuses primarily on
biofluid-based molecular biomarkers, such as circulating tumor DNA
(ctDNA) as well as circulating tumor cells (CTCs), and protein-based
circulating biomarkers. There is much interest in the potential of
ctDNA for developing biological fluid-based biopsies (such as using
plasma, urine, or other biofluids) and the presenters in this track
bring together the most up-to-date information and current
state-of-the-field. The conference further explores the potential of various minimally-invasive circulating
biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and
Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring and minimal residual disease detection. This conference is held concurrently with the Circulating Biomarkers 2019 Conference enabling delegates full access to the scientific presentations in both conferences, co-located exhibit hall, and extensive networking opportunities.
Information and Local Registration Facilities for this Conference are also available in: Japanese
|
 Korean
|
 Chinese (Simplified)
|
 Chinese (Traditional)
Call for PapersIf you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now! Oral Presentation Submission Deadline: 30 November 2018 Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 15 March 2019 Agenda Topics- Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
- Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
- Emerging Technologies and Emerging Companies Showcase
- Technology Platforms for Interrogation
- Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
- Microfluidics Platforms for Diagnostics Development
- US vs. EU vs. Asia/Pacific Regulatory Landscape for Liquid Biopsies
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Confirmed Speakers to dateBrian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
Taylor Jensen, Director, Research and Development, Sequenom (a LabCorp Company)
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)
Jean-François Martini, Sr. Director, Translational Oncology, Immuno-Oncology, Early Development, Pfizer
Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech
Victor Ugaz, Professor & Holder of the Charles D. Holland ’53 Professorship, Artie McFerrin Department of Chemical Engineering, Texas A&M University
Kang Zhang, Founding Director, Institute for Genomic Medicine, University of California-San Diego
Jasmine Zhou, Professor, University of California-Los Angeles
Yazhen Zhu, Assistant Project Scientist, David Geffen School of Medicine at UCLA
Bernhard Zimmermann, Vice President of Research and Development, Natera
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2019-03-27 00:00:002019-03-29 00:00:00Europe/LondonLiquid Biopsies 2019Liquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com
Exosomes Technology Analysis Slide Deck 2018
